Royce & Associates’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-60,999
Closed -$314K 893
2024
Q2
$314K Buy
60,999
+14,785
+32% +$76K ﹤0.01% 823
2024
Q1
$323K Buy
46,214
+6,377
+16% +$44.6K ﹤0.01% 814
2023
Q4
$353K Buy
+39,837
New +$353K ﹤0.01% 814